Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The NPO Organization for Treatment of Peritoneal Dissemination is a specialized medical and research entity founded and led by Dr. Masataka Yonemura, a world-renowned surgeon in the field of peritoneal surface malignancies. The organization focuses on the development and implementation of comprehensive treatment protocols for peritoneal carcinomatosis, most notably the 'Yonemura Method' which combines cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). It operates as a hub for clinical trials, physician training, and patient support, aiming to standardize advanced surgical techniques for late-stage abdominal cancers. The organization is instrumental in advancing the use of bidirectional chemotherapy (BIPSC) and extensive intraoperative peritoneal lavage (EIPL) to improve survival rates in patients with previously untreatable peritoneal dissemination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yonemura Masataka.